berberine has been researched along with Graves Disease in 1 studies
Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Z | 1 |
| Cen, C | 1 |
| Ou, Q | 1 |
| Pan, Y | 1 |
| Zhang, J | 1 |
| Huo, D | 1 |
| Chen, K | 1 |
1 other study available for berberine and Graves Disease
| Article | Year |
|---|---|
The Potential Prebiotic Berberine Combined With Methimazole Improved the Therapeutic Effect of Graves' Disease Patients Through Regulating the Intestinal Microbiome.
Topics: Berberine; Biomarkers; Disease Management; Drug Therapy, Combination; Dysbiosis; Gastrointestinal Mi | 2021 |